BAX
30
4
CPB
24
2
BA
49
-3
SEE
52
6
HSIC
51
-3
CVX
44
-2
PNR
69
4
EQR
59
5
AA
60
9
KR
38
4
DG
4
2
TRV
56
3
MTB
65
2
KHC
11
2
HD
55
8
OKE
81
3
ROP
59
5
EQIX
62
2
HPE
61
6
PDCO
38
3
BAX
30
4
CPB
24
2
BA
49
-3
SEE
52
6
HSIC
51
-3
CVX
44
-2
PNR
69
4
EQR
59
5
AA
60
9
KR
38
4
DG
4
2
TRV
56
3
MTB
65
2
KHC
11
2
HD
55
8
OKE
81
3
ROP
59
5
EQIX
62
2
HPE
61
6
PDCO
38
3
Financhill
Back

Mirum Pharmaceuticals 10K Form

Buy
69

MIRM
Mirum Pharmaceuticals

Last Price:
44.72
Seasonality Move:
41.89%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive MIRM News And Ratings

See the #1 stock for the next 7 days that we like better than MIRM

MIRM Financial Statistics

Sales & Book Value

Annual Sales: $186.37M
Cash Flow: $-6.2M
Price / Cash Flow: 0
Annual Sales: $4.84
Price / Book: 9

Profitability

EPS (TTM): -2.06950
Net Income (TTM): $-99.81M
Gross Margin: $139.34M
Return on Equity: -41.13%
Return on Assets: -15.23%

Mirum Pharmaceuticals Earnings Forecast

Key Mirum Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 4 years for MIRM is 74.76%.
  • The Selling, General & Administrative Expenses for MIRM have been equal to 78.27% of Gross Profit Margin.
  • The Research & Development expenses have been 55.06% of Revenue.
  • The Interest Expense is -9.24% of Operating Income.
  • The Net Earning history of MIRM is -87.68% of Total Revenues.
  • Per Share Earnings over the last 5 years have been positive in 3 years.

Mirum Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: MIRM
CUSIP: 604749
Website: mirumpharma.com

Debt

Debt-to-Equity Ratio: 1.33
Current Ratio: 3.34
Quick Ratio: 3.05

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

MIRM Technical Analysis vs Fundamental Analysis

Buy
69
Mirum Pharmaceuticals (MIRM) is a Buy

Is Mirum Pharmaceuticals a Buy or a Sell?